The severity of clinical presentation of type 1 diabetes in children does not significantly influence the pattern of residual β-cell function and long-term metabolic control

Pediatric Diabetes

Volumn 4, Issue 1, 2003, Pages 4-9

  Salardi, Silvana ^a   Zucchini, Stefano ^a   Cicognani, Alessandro ^a   Corbelli, Elena ^a   Santoni, Roberta ^a   Ragni, Luca ^a   Elleri, Daniela ^a   Cacciari, Emanuele ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

C peptide; Clinical onset of diabetes; Ketoacidosis; Metabolic control; Type 1 diabetes mellitus

Indexed keywords

C PEPTIDE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; HLA DR3 ANTIGEN; HLA DR4 ANTIGEN; INSULIN;

ADOLESCENT; ARTICLE; CALCULATION; CELL FUNCTION; CELL SECRETION; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETIC KETOACIDOSIS; DISEASE SEVERITY; DOSE RESPONSE; FOLLOW UP; HETEROZYGOSITY; HUMAN; HYPERGLYCEMIA; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; JUVENILE DIABETES MELLITUS; MAJOR CLINICAL STUDY; METABOLIC REGULATION; PANCREAS ISLET BETA CELL; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS;

ADOLESCENT; ADULT; BLOOD; BLOOD GLUCOSE; C-PEPTIDE; CHILD; DIABETES MELLITUS, TYPE 1; DIABETIC KETOACIDOSIS; HEMOGLOBIN A, GLYCOSYLATED; HETEROZYGOTE; HLA-DR3 ANTIGEN; HLA-DR4 ANTIGEN; HUMANS; HYDROGEN-ION CONCENTRATION; HYPERGLYCEMIA; ISLETS OF LANGERHANS; RETROSPECTIVE STUDIES;

EID: 0038105972     PISSN: 1399543X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-5448.2003.00028.x     Document Type: Article

References (17)

1. KOLB H, GALE EAM. Does partial preservation of residual beta-cell function justify immune intervention in recent onset type I diabetes? Diabetologia 2001: 44: 1349-1353.
2. LUDVIGSSON J, HEDING LG. C-Peptide in children with juvenile diabetes. A preliminary report. Diabetologia 1976: 12: 627-630.
3. KOMULAINEN J, LOUNAMAA R, KNIP M, KAPRIO EA, ÅKERBLOM HK, and the Childhood Diabetes in Finland Study Group. Ketoacidosis at the diagnosis of type 1 (insulin dependent) diabetes mellitus is related to poor residual beta cell function. Arch Dis Child 1996: 75: 410-415.
4. BONFANTI R, BAZZIGALUPPI E, CALORI G et al. Parameters associated with residual insulin secretion during the first year of disease in children and adolescents with type 1 diabetes mellitus. Diabet Med 1998: 15: 844-850.
5. MONTAÑYA E, FERNANDEZ-CASTAÑER M, SOLER J. Improved metabolic control preserved beta-cell function two years after diagnosis of insulin-dependent diabetes mellitus. Diabetes Metab 1997: 23: 314-319.
6. SOCHETT EB, DANEMAN D, CLARSON C, EHRLICH RM. Factors affecting and patterns of residual insulin secretion during the first year of type 1 (insulin-dependent) diabetes mellitus in children. Diabetologia 1987: 30: 453-459.
7. MADSBAD S, KRARUP T, FABER OK, BINDER C, REGEUR L. The transient effect of strict glycaemic control on B cell function in newly diagnosed type 1 (insulin-dependent) diabetic patients. Diabetologia 1982: 22: 17-22.
8. SJOBERG S, GUNNARSSON R, GJOTTERBERG M et al. Residual insulin production, glycaemic control and prevalence of microvascular lesions and polyneuropathy in long-term type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1987: 30: 208-213.
9. THE DIABETES CONTROL AND COMPLICATIONS TRIAL RESEARCH GROUP. Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. Ann Intern Med 1998: 128: 517-523.
10. MADSBAD S. Prevalence of residual B cell function and its metabolic consequences in type 1 (insulin-dependent) diabetes. Diabetologia 1983: 24: 141-147.
11. KLEIN R, KLEIN BEK, MOSS SE. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XVI. The relationship of C-peptide to the incidence and progression of diabetic retinopathy. Diabetes 1995: 44: 796-801.
12. FERNANDEZ-CASTAÑER M, MONTAÑA E, CAMPS I et al. Ketoacidosis at diagnosis is predictive of lower residual beta-cell function and poor metabolic control in type 1 diabetes. Diabetes Metab 1996: 22: 349-355.
13. KOMULAINEN J, KULMALA P, SAVOLA K et al. Clinical, autoimmune, and genetic characteristics of very young children with type 1 diabetes. Diabetes Care 1999: 22: 1950-1955.
14. POZZILLI P, VISALLI N, BUZZETTI R et al. Metabolic and immune parameters at clinical onset of insulin-dependent diabetes: a population-based study. Metabolism 1998: 47: 1205-1210.
15. HAUMONT D, DORCHY H, TOUSSAINT D, DESPONTIN M. Exogenous insulin needs. Relationship with duration of diabetes, C-peptidemia, insulin antibodies, and retinopathy. Helv Paediat Acta 1982: 37: 143-150.
16. DORCHY H, DESPONTIN M, HAUMONT D, TOUSSAINT D, LOEB H. Sécrétion résiduelle d'insuline chez les jeunes diabétiques. Relations avec la durée du diabète, le controle métabolique et la rétinopathie. Arch Fr Pediatr 1982: 39: 145-148.
17. EFF C, FABER O, DECKERT T. Persistent insulin secretion, assessed by plasma C-peptide estimation in long-term juvenile diabetics with a low insulin requirement. Diabetologia 1978: 15: 169-172.